Erste Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,000
| Closed | -$52.2K | – | 651 |
|
|
2024
Q3 | $52.2K | Hold |
15,000
| – | – | ﹤0.01% | 513 |
|
|
2024
Q2 | $71.1K | Hold |
15,000
| – | – | ﹤0.01% | 502 |
|
|
2024
Q1 | $112K | Hold |
15,000
| – | – | ﹤0.01% | 486 |
|
|
2023
Q4 | $155K | Hold |
15,000
| – | – | ﹤0.01% | 491 |
|
|
2023
Q3 | $104K | Hold |
15,000
| – | – | ﹤0.01% | 500 |
|
|
2023
Q2 | $122K | Hold |
15,000
| – | – | ﹤0.01% | 513 |
|
|
2023
Q1 | $105K | Hold |
15,000
| – | – | ﹤0.01% | 528 |
|
|
2022
Q4 | $135K | Hold |
15,000
| – | – | ﹤0.01% | 525 |
|
|
2022
Q3 | $182K | Hold |
15,000
| – | – | ﹤0.01% | 501 |
|
|
2022
Q2 | $183K | Hold |
15,000
| – | – | ﹤0.01% | 515 |
|
|
2022
Q1 | $293K | Buy |
+15,000
| New | +$293K | 0.01% | 484 |
|
|
2021
Q4 | – | Sell |
-19,000
| Closed | -$808K | – | 639 |
|
|
2021
Q3 | $808K | Hold |
19,000
| – | – | 0.02% | 357 |
|
|
2021
Q2 | $876K | Hold |
19,000
| – | – | 0.02% | 356 |
|
|
2021
Q1 | $770K | Hold |
19,000
| – | – | 0.02% | 349 |
|
|
2020
Q4 | $1.42M | Hold |
19,000
| – | – | 0.04% | 304 |
|
|
2020
Q3 | $552K | Buy |
19,000
+6,000
| +46% | +$174K | 0.02% | 345 |
|
|
2020
Q2 | $381K | Hold |
13,000
| – | – | 0.02% | 355 |
|
|
2020
Q1 | $263K | Hold |
13,000
| – | – | 0.02% | 337 |
|
|
2019
Q4 | $396K | Hold |
13,000
| – | – | 0.02% | 337 |
|
|
2019
Q3 | $292K | Hold |
13,000
| – | – | 0.02% | 347 |
|
|
2019
Q2 | $304K | Hold |
13,000
| – | – | 0.02% | 348 |
|
|
2019
Q1 | $307K | Hold |
13,000
| – | – | 0.02% | 335 |
|
|
2018
Q4 | $264K | Buy |
+13,000
| New | +$264K | 0.02% | 348 |
|